Free Trial
→ I was right about SpaceX (From Brownstone Research) (Ad)tc pixel Free IONS Stock Alerts

Ionis Pharmaceuticals (IONS) Earnings Date, Estimates & Call Transcripts

Ionis Pharmaceuticals logo
$75.32 -0.39 (-0.51%)
As of 02:15 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Ionis Pharmaceuticals Earnings Summary

Ionis Pharmaceuticals announced Q1 2026 earnings on April 29, 2026, reporting an EPS of -$0.56, which topped the consensus estimate of -$0.85 by $0.29. Quarterly revenue rose 86.4% year-over-year to $246 million, above analysts' expectations of $195.57 million. With a trailing EPS of -$2.07, Ionis Pharmaceuticals' earnings are expected to grow next year, from ($3.76) to ($1.95) per share.

Latest Q1
Earnings Date
Apr. 29Estimated
Consensus EPS
(Apr. 29)
-$0.85
Actual EPS
(Apr. 29)
-$0.56 Beat By $0.29
Actual Revenue
(Apr. 29)
$246.00M

Q1 2026 Earnings Resources

Slide Deck

Ionis Pharmaceuticals' Q1 2026 Slide DeckFull Screen Slide Deck
Powered by Quartr
Get Ionis Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ionis Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

IONS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

IONS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ionis Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue Guidance
Q1 20262-$0.81-$0.70-$0.76
Q2 20262-$0.82-$0.60-$0.71
Q3 20262-$0.90-$0.43-$0.67
Q4 20262-$0.73-$0.39-$0.56
FY 2026 8 -$3.26 -$2.12 -$2.69
Q1 20271-$0.62-$0.62-$0.62
Q2 20271-$0.57-$0.57-$0.57
Q3 20271$0.11$0.11$0.11
Q4 20271$0.26$0.26$0.26

Ionis Pharmaceuticals Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
4/29/2026Q1 2026-$0.85-$0.56+$0.29-$0.56$195.57M$246.00M
2/25/2026Q4 2025-$1.23-$1.41 -$0.18-$1.41$156.07M$203.33M
10/29/2025Q3 2025-$1.15-$0.80+$0.35-$0.80$131.75M$156.72M
7/30/2025Q2 2025$0.19$0.70+$0.51$0.70$270.90M$452.00M
4/30/2025Q1 2025-$1.07-$0.93+$0.14-$0.93$144.31M$132.00M
2/19/2025Q4 2024-$1.12-$0.66+$0.46-$0.66$140.97M$227.00M
8/1/2024Q2 2024-$0.92-$0.45+$0.47-$0.45$152.35M$225.00M

Data powered by Fiscal.ai.

Ionis Pharmaceuticals Earnings - Frequently Asked Questions

Ionis Pharmaceuticals (NASDAQ:IONS) last announced its quarterly earning data on Wednesday, April 29, 2026. Learn more on IONS's earnings history.

Ionis Pharmaceuticals issued an update on its FY 2026 earnings guidance on Wednesday, April, 29th. The company issued revenue guidance of $875.0 million-$900.0 million, compared to the consensus revenue estimate of $816.3 million.

In the previous quarter, Ionis Pharmaceuticals (NASDAQ:IONS) reported ($0.56) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.85) by $0.29. Learn more on analysts' earnings estimate vs. IONS's actual earnings.

The conference call for Ionis Pharmaceuticals' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Ionis Pharmaceuticals' latest earnings report can be read online.
Read Transcript

Ionis Pharmaceuticals' earnings report can be found in their filing with the SEC.
View SEC filing

Ionis Pharmaceuticals (NASDAQ:IONS) has a recorded annual revenue of $944 million.

Ionis Pharmaceuticals (NASDAQ:IONS) has a recorded net income of -$381.39 million. IONS has generated -$2.07 earnings per share over the last four quarters.

Ionis Pharmaceuticals' earnings are expected to grow from ($3.76) per share to ($1.95) per share in the next year.

Related Companies
Earnings Tools

This page (NASDAQ:IONS) was last updated on 5/11/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
A little-known stock pick with money-doubling potential over the next year is revealed for free in the first t...
Paradigm Press | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel